Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Baxter
Harvard Business School
Johnson and Johnson
Mallinckrodt

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for DAIICHI PHARMACEUTIC v. APOTEX INC. (D.N.J. )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in DAIICHI PHARMACEUTIC v. APOTEX INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for DAIICHI PHARMACEUTIC v. APOTEX INC. (D.N.J. )

Date Filed Document No. Description Snippet Link To Document
2005-11-01 124 prosecution of Daiichi’s U.S. Patent No. 5,401,741 (“the ‘741 patent”). Apotex’s arguments…the field of patent law. Mr. Killworth has over 35 years’ experience in patent law as a… Customs and Patent Appeals, and as a registered patent attorney. Kidd Decl., Exhibit A. …Mr. Killworth has limited experience at the U.S. Patent and Trademark Office (“PTO”) and that he is … a patent examiner, law clerk and technical advisor to Judge Almond of the United States Court of Customs External link to document
2005-11-01 128 during the prosecution of its U.S. Patent No. 5,401,741 (“the ‘741 patent”), entitled a “Topical Preparation…that an erroneous publication date for another patent provided in Daiichi’s Information Disclosure … The IDS disclosed the existence of a German patent identified as DE 3,632,222 (“Grohe ‘222”) and… qualified to testify as an expert in Patent and Trademark Office practice and procedure …it prior to submitting it to the United States Patent and Trademark Office (“PTO”). Based on Mr External link to document
2005-11-01 130 alleging patent infringement of all seven claims of Daiichi’s U.S. Patent No. 5,401,741 (“the ‘741… to a patent unless... (f) he did not himself invent the subject matter sought to be patented....” …failing to name the proper inventors of Daiichi’s patent pursuant to 35 U.S.C. § 102(f). For…‘741 patent”), entitled a “Topical Preparation for Treating Otopathy.” Daiichi now argues that… defense that it is not entitled to the ‘741 patent for failure to name the proper inventors pursuant External link to document
2006-07-21 181 alleging that Apotex infringed Daiichi’s U.S. Patent No. 5,401,741. After the culmination of the nine day…. Hedden, 149 U.S. 304, 306 (1893)). In patent cases, however, where the definition of a term … 415 F.3d 1303, 1319 (Fed. Cir. 2005). Patent cases are complex suits that often hinge on the…Supreme Court, has held that disputed terms in a patent suit are to be determined as a matter of law.…often resolves disputes concerning terms in a patent during a pre-trial “Markman” hearing. Id. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Express Scripts
Colorcon
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.